Actively Recruiting
Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Led by University of Sao Paulo · Updated on 2024-12-09
40
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.
CONDITIONS
Official Title
Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet classification criteria by EULAR/ACR 2017
- Meet classification criteria by Connors et al.
You will not qualify if you...
- Have neoplasia (cancer)
- Use a heart pacemaker
- Have metallic clips inside the body
- Have infections such as HIV, HTLV-1, or Hepatitis
- Are pregnant
- Have a history of convulsions or epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samuel K Shinjo
São Paulo, São Paulo, Brazil
Actively Recruiting
Research Team
S
Samuel K Shinjo, PhD
CONTACT
S
Sao Paulo University
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here